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Introduction
The study of medicine "begins with the bodily functions. Porphyrin disturbances patient, continues with the patient and of various types following chemical and ends ... with the patient," according to heavy metal exposures were reported by William Osler (1) . Exposure to chemicals, several authors in a special conference on particularly petrochemicals and combus-chemically induced porphyrinopathies tion products, has been associated in the sponsored by the New York Academy of literature with a variety of alterations in Sciences (2) . Abnormally elevated levels of urinary coproporphyrins were reported in several papers, but other fecal and urinary porphyrins could be increased as well. Specific types of heavy metal and petrochemical exposures seem to cause specific patterns of porphyrin disturbance in rats (3) . Chlorinated benzenes can induce porphyria in rats (4) , and small exposures (such as swallowed mouthwash) can aggravate congenital porphyria (5) . Immune disturbances following chemical exposure have been reported by several authors. In the following immune references, patients were studied only after probable causal exposure and the results were compared to those of laboratory normals. Impaired mitogenesis has been noted after exposure to chlordane (6) and isocyanates (7) . A higher number of helper cells have been described in workers exposed to solvents (8) and isocyanates (7) , and in persons consuming chlorinated solvents in drinking water (9) . A greater number of immune complexes are reported with vinyl chloride exposure, and scleroderma has been noted after aromatic or chlorinated solvent exposure (10) . Immune activation with higher levels of TAI/CD26 has been reported with isocyanates (7), formaldehyde (11) , formaldehyde with aliphatic amines (12) , silicone (13) , chlordane and chlorpyrifos (14) , and sick-building exposures (15) .
Higher levels of abnormalities in various autoantibodies are described after a wide variety of chemical exposures, including chlordane (6) , solvents (16, 17) , chlorinated solvents (9) , polychlorinated biphenyls and polybrominated biphenyls (18) , organochlorine, organophosphate and other pesticides (19) , formaldehyde and aliphatic amines (12) , silicone (13, 20) , chlordane (14) , chlorpyrifos (14) , malathion (14) , and formaldehyde (11) . A greater number of chemical-specific antibodies has been noted after exposure to building materials in remodeling (21) . Suppression of mitogenesis (22) and natural killer cell (NK) function (23) has been described following anesthesia induced by petrochemical agents. Reduced NK function in multiple chemical sensitivity (MCS) patients also has been reported by Heuser (24) .
Neurologic effects long have been associated with exposure to petrochemicals. Solvent exposure is associated with autonomic dysfunction (25) , neurocognitive impairment (26, 27) , vestibular abnormalities (28) , and impaired hearing (29) . In a study of the effects of solvents on 15
Environmental Health Perspectives -Vol 105, Supplement 2 * March 1997 industrial painters (30) , impairment was observed on a variety of neuropsychological measures. The Halstead-Reitan Battery was administered and impairment was found on the Impairment Index, Trails A, Digit Symbol, Seashore Rhythm and Speech Sounds-Perception Tests. In addition, subjects reported personality change and decreased memory.
Neurological abnormalities in a group of organophosphate-exposed subjects were described using the Halstead-Reitan Battery (31) . Visual retention, memory dysfunction, and constructional deficits were reported (32) .
Studies on chlorinated hydrocarbon solvents have also shown adverse effects. Trichloroethylene in low concentrations and for relatively brief times can lead to significant and prolonged impairment (33) . Psychomotor speed and memory were two of the areas most affected, with the memory impairments characterized by storage and retrieval difficulties.
Neuropsychological changes have been found among community residents living in a supposedly benign environment such as areas adjacent to a wood-treating plant (34) . Of the 34 subjects tested, more than 40% had sensory impairments, 86% had motor or psychomotor speed problems, and 72% had concentration difficulties. Disturbed autonomic function has been reported with chemical sensitivity (35) , and abnormal neurocognitive function with chemical sensitivity/cacosmia (36) .
Chemical sensitivity has been reported in the literature following exposure to chlordane (14) , chlorpyrifos (37) , pesticides (38) , formaldehyde (39) , tight or sick buildings (15) , and organophosphates and solvents (40) . These (41) (42) (43) . Since depression and mood swings can occur with solvent/hydrocarbon exposures and with porphyrin disturbances, these are not in themselves evidence of a psychologic etiology of MCS (40) . These and other studies strongly suggest that chemical sensitivity is a physiologic not a psychologic disorder (35, 36, 44) .
A 1994 study found that 67% of patients with fibromyalgia and the same percentage with chronic fatigue syndrome (CFS) reported that their symptoms worsened on exposure to gas, paint, or solvent fumes, and 46 to 64% of these groups reported sensitivities to three other categories of common chemical exposures (45) . Fibromyalgia patients have shown reduced current perception threshold (46) and T-cell changes (47) . Chronic fatigue syndrome patients often meet criteria for fibromyalgia (48) and have impaired NK function, increased TA1/CD26, altered CD8, impaired mitogenesis (49, 50) , and vestibular and other neurologic abnormalities (51) . Both chemical sensitivity (52) and chronic fatigue syndrome (53) (54) .
Patients responding to the questionnaire came from many states from the eastern region of the United States, with most coming from the mid-Atlantic area. Most were referred by physicians not specializing in occupational medicine or toxic substances. Some were referred by patient support groups, friends, or relatives, and a few were legal referrals (although we have no data on the actual number in each category). Most but not all patients were well before the onset of their MCS. Former psychiatric diagnoses and treatment were unusual rather than typical.
In following these patients over time, Ziem's clinical impression is that patient responses to these two questions seem to correlate well with the clinical severity of their symptoms: sicker patients appear to have more frequent symptoms and to be affected by more exposures. However, it was not possible for this presentation to confirm this clinical impression by comparing response rates to exposures with clinical outcomes. This would be useful for future clinical studies. Symptom frequency can also be studied as an indicator of clinical severity.
These patients filled out the questionnaires at or shortly before their first visit. Some had been using some environmental controls; others had not. Many but not all patients were aware of chemical sensitivity as a potential problem for them. To assess the frequency of 51 different symptoms commonly associated with MCS, patients were asked in question 14 to describe whether these symptoms occur daily to almost daily, several times a week, once a week, several times per month, once per month or less, rarely, if ever, or not sure. In the analysis below, daily or almost daily responses are combined with several times a week or more responses to obtain a total figure for frequent symptoms.
All patients reporting increased sensitivity to chemicals accompanied by chronic illness were included in this analysis. They typically had frequent recurring or chronic symptoms in more than one organ system for over 6 months before completing the questionnaire. For some items in question 14 , responses were only available for 89 or 90 patients: the bar graph in Figure 1 shows the number of patients (n) answering for each question. (Table 1) . Data on the three other patients screened are not included, as they each had undergone only one or two of the recommended tests, although two patients showed some abnormalities-one with decreased coproporhyrinogen oxidase (but no urine or fecal testing) and one with increased urinary coproporphyrins (but no blood or stool testing). In terms of both symptoms and history, the patients tested for porphyrin disorders were fairly representative of all chemically sensitive patients in this medical practice and none were known to have any other disorder associated in the literature with abnormal porphyrin metabolism (such as lead poisoning, hepatitis C, or liver cancer).
Patients (Table 5 ). The only ISL data excluded after analysis are those on MY, GP, SG, and AS neural autoantibodies, each of which were tested in less than five patients, although some other parameters were not analyzed for this paper.
Autoantibody levels were normal for most antigens, but 7 of 21 showed increased levels compared to laboratory normals for both rheumatoid factor and total immune complex. Patients For a patient whose chemical sensitivity was thought to be caused by occupational exposure to carbonless copy paper, we compared immune measurements before the patient left and after she returned to her job, which required sitting near and working with large quantities of carbonless copy paper (Table 6 ). These data suggest that immune measures pre-and postchallenge testing are unlikely to show major changes. The patient had been away from exposure for many months and showed significant clinical improvement. Chemical sensitivity has been seen in a hundred patients with substantial occupational exposure to carbonless copy paper (E Panitz, personal communication).
In 1994, a few physicians began testing for porphyrin disturbances in chemically injured patients previously diagnosed with MCS. Like patients with some types of congenital porphyria, chemically sensitive patients frequently describe intolerance to small amounts of alcohol and many synthetic (petrochemical) medications, ingestion of which provokes acute outbreaks of neurological and psychological symptoms such as imbalance, tremor, abdominal pain, and mood swings as well as symptoms or signs of autonomic involvement such as rapid heart rate and increased blood pressure. Patients also sometimes exhibit cutaneous symptoms of photosensitivity such as skin rashes and other lesions.
Intrigued by informal reports of porphyrin abnormalities being found in over 70% of MCS patients being tested (57), Ziem 2 had elevations in both of these, and 1 had elevated coproporphyrins and uroporphryins. Of the 11 patients with stool evaluations, 3 showed abnormalities: 1 had only elevated coproporhyrins, 1 had only elevated protoporphrins, and the third patient had elevated copro-, uro-and protoporphyrins. Those with elevated fecal coproporphyrins also had elevated urinary coproporhyrins. One patient submitted a stool specimen that Mayo felt was too small to represent a 24-hr sample, so this result was not included.
All patients were given blood tests for the activity of porphyrin-related enzymes. The most common enzyme deficiency was in the activity of coproporhyrinogen oxidase (CpgO), which was below normal in 9 of the 14 patients tested. CpgO On the WAIS-R neuropsychological evaluation done by McTamney (Table 2) , 6 of the 13 MCS patients tested showed a significant difference of 15 points between the verbal and performance phases of the test, all scoring higher on the verbal portion. Only one patient scored in the superior range for IQ with no apparent difficulties.
The Halstead-Reitan battery showed a number of significant scores indicating impairment (Table 3) . On the Category test, 53% of patients scored in the impaired range. On the Tactile Performance test, 60% scored in the impaired range on the total time required to complete the three trials. None of the patients had problems with the dominant hand, while 30% were slower with the nondominant hand despite the previous trial with the dominant hand. Twenty-three percent of patients scored in the impaired range on the memory phase of the Tactile Performance test, while 84% scored in this range on the Localization Scale. symptoms, with patients tested consistently both more common diagnoses whose which he asserts is "no better than chance during both acute and nonacute phases. symptoms have been found to overlap on most of their measures," but he also
Discrepancies are found between our those of multiple chemical serjitivity (and admits that these critical data on test reproimmune testing results and those of Simon of each other) so as to be almost indistin-ducibility were not published in his paper et al. (60) . Simon found significantly lower guishable in as many as 67% of all cases (56) . Given these problems, and the TAI/CD26 cell activation among MCS (45, 61 (63) and in patients with chemical sensitivity (42, 64, 65) . One of our patients developed new onset of Raynaud's phenomenon (a vasospastic disorder), which we observed to be triggered by doubleblinded finger contact with carbonless copy paper (the probable cause of her chemical sensitivity). Only a few patients developed new onset of high blood pressure (another vasospastic response), which is seen primarily following exposure (their blood pressure readings usually remained normal between exposures). These vasospastic responses may involve abnormal autonomic function, which has been observed to occur with chemical sensitivity (35) .
Diagnoses of fibromyalgia and chronic fatigue syndrome are common among our MCS patients (currently 75 and 85%, respectively). We recommend further research on the incidence of chemical sensitivity in these groups using the types of screening questionnaires developed by Kipen, Bell, and Davidoff. If these disorders are essentially the same, much of the research already done for fibromyalgia and chronic fatigue syndrome may also apply to MCS; this could reduce research costs and time delays. Increased sensitivity to chemicals also occurs with migraine, asthma, and other disorders. However, fibromyalgia syndrome, chronic fatigue syndrome, and porphyrin disorders are multiple-system disorders involving chemical sensitivity.
Over one-third of our patients described tremor several times or more a month (Figure 1 ). Several patients were told by other physicians that they were developing Parkinson's disease during more serious periods of their illness only to have the diagnosis rescinded when they improved after environmental controls were put in place to reduce exposures. Parkinson's disease has been reported following pesticide exposure (66) .
Nearly half our patients reported increased symptoms during or after swimming in a chlorinated pool (Figure 3) , which has been associated with increased chloroform levels (67) . Patients also often reported reduced symptoms during and after showering with, compared to without, an activated charcoal filter that helps remove chloroform. Longer showers and/or those with greater flow rates release more chloroform and other chlorinated products. Water filters that reduce chlorine therefore appear to be a reasonable control for MCS.
In addition to filters for chlorinated water, other reasonable means exist to control exposures that aggravate MCS symptoms. Aggravation from vehicle exhaust (Figure 2 ) can be reduced by using an auto filter device that provides activated charcoal filtration and by avoiding ozonating devices which generate irritants. Symptom exacerbation from pesticides, cleaning products, building materials, etc. can be reduced by using less toxic products. Reasonable accommodation at the work place, at home (apartments, condominiums, etc.) and at school and public areas could be available to those with this debilitating condition by requesting that less toxic products and procedures be used. Further helpful suggestions are discussed in our Environmental Control Plan (68) .
In our 10-year experience with chemically sensitive patients, no patients lost their sensitivity to chemicals. No patients were able to go to problem environments (new carpets, recent pesticides, etc.) consistently without deterioration of their conditions. Thus, MCS should be considered a permanent condition. Some patients were able to continue working if their employers provided nontoxic accommodations for their conditions. More than half the patients continued to be too sick to work under the prevailing conditions at the work place. We believe this proportion could be reduced if society pays more attention to use of nontoxic products.
The large and growing epidemic of chemical sensitivity in the United States is partly because of inadequate exposure limits for chemicals. These exposure limits have been shown to lack scientific merit (69) and to have been seriously influenced by vested interests (70) (71) (72) (73) Immune activation also could lead to increased response to foreign substances, such as conventional allergens. We note in our patients an apparent high rate of new onset of allergies to mold, dander, etc., following onset of chemical sensitivity. Kipen reports what appears to be a significant level of sensitivity to chemicals among asthmatics (77) . Asthma also is increased with higher levels of indoor volatile organic compounds (VOCs), formaldehyde and/or limonene (78) . Persons with other allergic diatheses also should be studied for sensitivity to chemicals. If indeed chemical exposure via immune activation contributes significantly to the high and increasing rates of allergies, we may have the means to counter this alarming trend.
Studies of chemically injured populations should compare MCS patients with specific and identifiable initial exposures to MCS patients who cannot identify any specific triggering exposure. Other patient groups that should be studied for MCS include those with recurring migraines, chronic sinusitis or rhinitis, degenerative neurologic diseases (such as acute types of congenital porphyria), autoimmune disorders (such as multiple sclerosis, autoimmune hepatitis, rheumatoid arthritis, and lupus), hyperactive children, and patients with attention deficit disorder. Chemically exposed groups also merit study, especially those that have avoided further occupational exposures following work with pesticides, solvents, etc. We believe such studies will find levels of chemical sensitivity in these subpopulations that are considerably greater than currently recognized. 
